Study on FAS/FAS-L expression in liver tissue and hepatocyte apoptosis in patients with hepatitis gravis

Abstract

To explore the expression of Fas/Fas-L in liver tissue of hepatitis gravis patients and its implication in hepatocyte apoptosis, Fas/Fas-L expression and cell apoptosis was detected by the means of inmmunohistochemistry and terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNED. It was found that in the 20 patients with clinical hepatitis gravis, Fas in hepatocytes showed strong expression and Fas-L also showed intensive expression in infiltrating lymphocytes and scattering hepatocytes. The apoptosis existed in all the samples, scattering in the area of inflammatory, necrotic area and hepatic lobule. It was suggested that the overexpression of Fas/Fas-L could cause the death of hepatocytes and thus the occurrence of hepatitis gravis. The apoptosis caused by Fas might be one of the important pathogeneses of hepatitis gravis. Among the detected samples, apoptosis and necrosis coexisted, indicating that both two types of cellular death were closely associated with the pathogenesis of hepatitis gravis.

Keywords

hepatitis gravis / FAS/FAS-L / apoptosis

References

[1] RyoK, KamogawaY, LkedaI, et al.. Fas and Fas ligand strongly expressed in liver of fulminant hepatitis patients. Hepatology, 1995, 22: 230A-230A

[2] KondoT, SudaT, FukuyamaH, et al.. Essential role of the Fas-ligand in the development of hepatitis. Nat Med, 1997, 3: 409-409

[3] GanterF, LeistM, LchseA W. Concanavalin A-induced T-cell mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology, 1995, 21: 190-190

[4] KagiD, VignaurF, LedermannB, et al.. Fas perforin pathways are major mechanisms of T cell mediated cytotoxicity. Science, 1994, 265: 528-528

[5] RyoK, KamogawaY, YamauchiK, et al.. Involvement of Fas and Fas ligand in case of human fulminant hepatitis. Nippon Rinsho, 1996, 54(7): 1965-1965

[6] GalleP R, KrammerP H. CD95-induced apoptosis in human liver disease. Semin Liver Dis, 1998, 18(2): 141-141

[7] NagataS, GolsteinP. The Fas death factor. Science, 1995, 267(5203): 1449-1449

[8] AndoK, HiroishiK, KanekoT, et al.. Perforin, Fas/Fas ligand, and TNF-altha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol, 1997, 158(11): 5283-5283

[9] DayanC M, ElsegoodK A, MaileR, et al.. FasL expression on epithelial cells; the Bottazza Feldman hypothesis revisited. Immunol Today, 1997, 18: 203-203